BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14967369)

  • 1. Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study.
    D'Angelo A; Davies R; Salah E; Nix BA; Amso NN
    Fertil Steril; 2004 Feb; 81(2):332-6. PubMed ID: 14967369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
    Barak V; Elchalal U; Edelstein M; Kalickman I; Lewin A; Abramov Y
    Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
    Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
    Gera PS; Tatpati LL; Allemand MC; Wentworth MA; Coddington CC
    Fertil Steril; 2010 Jun; 94(1):173-8. PubMed ID: 19356753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
    Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
    Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
    Ayustawati ; Shibahara H; Hirano Y; Suzuki T; Takamizawa S; Suzuki M
    Fertil Steril; 2004 Sep; 82(3):579-85. PubMed ID: 15374699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation.
    Abdalla H; Nicopoullos JD
    Fertil Steril; 2010 Oct; 94(5):1757-63. PubMed ID: 19939366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
    Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
    Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
    Esinler I; Bayar U; Bozdag G; Yarali H
    Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle].
    Miao MF; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):114-7. PubMed ID: 16640861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
    Mansour R; Aboulghar M; Serour G; Amin Y; Abou-Setta AM
    Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.